ARWR vs BILL · rev $829.4M vs rev $1.65B
Arrowhead Pharmaceuticals Inc (ARWR) versus Bill Com Holdings Inc (BILL) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
ARWR currently screens at market cap $10.59B. BILL currently screens at market cap $4.78B.
Not investment advice. Open the ARWR and BILL stock pages for the full models.
Not investment advice.